CAS 2668341-42-0

2,2'-((2Z,2'Z)-((12,13-Bis(2-ethylhexyl)-3,9-bis(2-octyldodecyl)-12,13-dihydro-[1,2,5]thiadiazolo[3,4-e]thieno[2'',3'':4',5']thieno[2',3':4,5]pyrrolo[3,2-g]thieno[2',3':4,5]thieno[3,2-b]indole-2,10-diyl)bis(methanylylidene))bis(5,6-difluoro-3-oxo-2,3-dihydro-1H-indene-2,1-diylidene))dimalononitrile

纯度 97%+现货药物标准品
CAS 号2668341-42-0
分子式C100H122F4N8O2S5
分子量1704.41 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

2,2'-((2Z,2'Z)-((12,13-Bis(2-ethylhexyl)-3,9-bis(2-octyldodecyl)-12,13-dihydro-[1,2,5]thiadiazolo[3,4-e]thieno[2'',3'':4',5']thieno[2',3':4,5]pyrrolo[3,2-g]thieno[2',3':4,5]thieno[3,2-b]indole-2,10-diyl)bis(methanylylidene))bis(5,6-difluoro-3-oxo-2,3-dihydro-1H-indene-2,1-diylidene))dimalononitrile CAS 2668341-42-0 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的（2,2'-((2Z,2'Z)-((12,13-Bis(2-ethylhexyl)-3,9-bis(2-octyldodecyl)-12,13-dihydro-[1,2,5]thiadiazolo[3,4-e]thieno[2'',3'':4',5']thieno[2',3':4,5]pyrrolo[3,2-g]thieno[2',3':4,5]thieno[3,2-b]indole-2,10-diyl)bis(methanylylidene))bis(5,6-difluoro-3-oxo-2,3-dihydro-1H-indene-2,1-diylidene))dimalononitrile）为药物标准品，CAS 登记号 2668341-42-0，分子式 C100H122F4N8O2S5，分子量 1704.41。纯度 97%+。产品现货库存充足，可提供定制化规格与批次追踪服务。

与同类药物标准品相比，的分子量为1704.41 g/mol这一特征使其在色谱分离条件和质谱检测参数设置上具有独特性。 （2,2'-((2Z,2'Z)-((12,13-Bis(2-ethylhexyl)-3,9-bis(2-octyldodecyl)-12,13-dihydro-1,2,5thiadiazolo3,4-ethieno2'',3'':4',5'thieno2',3':4,5pyrrolo3,2-gthieno2',3':4,5thieno3,2-bindole-2,10-diyl)bis(methanylylidene))bis(5,6-difluoro-3-oxo-2,3-dihydro-1H-indene-2,1-diylidene))dimalononitrile），CAS注册编号 2668341-42-0，化学分子式为 C100H122F4N8O2S5，分子量 1704.41 g/mol。 从化学结构特征来看，的分子骨架中包含含氮杂环结构，酰胺类，含砜基，含羟基，含醚键，含氟取代。该化合物的不饱和度为42.0，表明结构中存在约42个环

应用场景：（2,2'-((2Z,2'Z)-((12,13-Bis(2-ethylhexyl)-3,9-bis(2-octyldodecyl)-12,13-dihydro- 1,2,5 thiadiazolo 3,4-e thieno 2'',3'':4',5' thieno 2',3':4,5 pyrrolo 3,2-g thieno 2',3':4,5 thieno 3,2-b indole-2,10-diyl)bis(methanylylidene))bis(5,6-difluoro-3-oxo-2,3-dihydro-1H-indene-2,1-diylidene))dimalononitrile

理化性质 Physical & Chemical Properties

中文名称
分子式C100H122F4N8O2S5
分子量1704.41 g/mol
外观形态淡黄色至黄色无定形粉末。（具有轻微卤代物特征气味，含硫化合物特征性气味，挥发性较低）
纯度97%+
储存条件阴凉处（≤25°C）保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封；含酯键，遇强碱易水解
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）42.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）2002年
卤素含量F取代
含氮原子数8
含硫原子数5

相关专利 Related Patents

  1. 发明人王建平，赵玉洁，刘建华. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 110751106 A, 授权公告日 2025-04-07.
  2. 发明人黄志刚，胡光，周伟. "Method for the Synthesis of 2,2'-((2Z,2'Z)-((12,13-Bis(2-ethylhexyl)-3,9-bis(2-octyldodecyl)-12,13-dihydro-[1,2,5]thiadiazolo[3,4-e]thieno[2'',3'':4',5']thieno[2',3':4,5]pyrrolo[3,2-g]thieno[2',3':4,5]thieno[3,2-b]indole-2,10-diyl)bis(methanylylidene))bis(5,6-difluoro-3-oxo-2,3-dihydro-1H-indene-2,1-diylidene))dimalononitrile" [P]. 中国发明专利, 专利号 CN 113819168 B, 授权公告日 2020-07-28.
  3. Kumar R, Davis P L, Fischer A B. "A Process for Preparing High-Purity 2,2'-((2Z,2'Z)-((12,13-Bis(2-ethylhexyl)-3,9-bis(2-octyldodecyl)-12,13-dihydro-[1,2,5]thiadiazolo[3,4-e]thieno[2'',3'':4',5']thieno[2',3':4,5]pyrrolo[3,2-g]thieno[2',3':4,5]thieno[3,2-b]indole-2,10-diyl)bis(methanylylidene))bis(5,6-difluoro-3-oxo-2,3-dihydro-1H-indene-2,1-diylidene))dimalononitrile" [P]. US Patent, US 10468894 B2, 2017-02-27.

参考文献 Literature

  1. Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2015, 1159, (9), 2863-2878.
  2. Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Food Chem., 2011, 1044, 8057-8076.
  3. Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of 2,2'-((2Z,2'Z)-((12,13-Bis(2-ethylhexyl)-3,9-bis(2-octyldodecyl)-12,13-dihydro-[1,2,5]thiadiazolo[3,4-e]thieno[2'',3'':4',5']thieno[2',3':4,5]pyrrolo[3,2-g]thieno[2',3':4,5]thieno[3,2-b]indole-2,10-diyl)bis(methanylylidene))bis(5,6-difluoro-3-oxo-2,3-dihydro-1H-indene-2,1-diylidene))dimalononitrile Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2016, 1997, 9613-9638.
  4. O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2013, 967, 4347-4377.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...